US-born science, commercialized with Japanese manufacturing.
Ascella Biosystems, Inc. was founded in 2020 in San Francisco on technology from Prof. Eric Kool's laboratory at Stanford University. Our Japanese subsidiary, Ascella Bio JAPAN, Inc., leads regulatory affairs, R&D and manufacturing scale-up with domestic partners.
Ascella for Anyone, Anytime, Anyplace.
Molecular diagnostics should not be a privilege of the laboratory. We are researching and developing a platform intended to bring molecular testing closer to clinics and care settings, so that treatment decisions can be made at the moment they matter most.
Headquartered in San Francisco, with R&D and manufacturing scale-up in Japan.
Ascella Biosystems, Inc.
San Francisco, CA
Holds the scientific assets. Product architecture, assay chemistry and systems engineering.
Ascella Bio JAPAN, Inc.
HQ: Tokyo / Lab: Kashiwa, Chiba
Regulatory affairs in Japan, R&D and manufacturing scale-up with domestic partners.
Milestones.
Founded
Ascella Biosystems established on technology from Prof. Eric Kool's lab at Stanford University.
Series A
Series A financing completed.
Ascella Bio JAPAN founded
Japanese subsidiary established to run R&D and regulatory work in Japan.
NIH RADx grant
Awarded a grant under the US NIH RADx program.
Integrated management
Moved to a single management team across the US and Japan.
Leadership team.
Prof. Eric Kool
Professor at Stanford University, working in organic chemistry, chemical biology and biophysics. A pioneer of rolling circle amplification (RCA) research in the 1990s, he works on isothermal amplification and the design of functional molecular tools.
Takahiro Suzuki, Ph.D.
Specialized in both wet and dry omics at RIKEN and Yokohama City University, working on cancer, hematologic malignancies and in vitro gametogenesis. Part-time lecturer at Juntendo University and Director at Wiz Partners.
Yuki Hasegawa, Ph.D.
Led a laboratory at RIKEN as deputy team leader and took part in the mouse cDNA and FANTOM projects. Established an exon profiling method using RecA. Also serves as CIO at Wiz Partners.
Ascella Biosystems, Inc.
- Company name
- Ascella Biosystems, Inc.
- Founded
- 2020
- Headquarters
- San Francisco, California, USA
- Chief Executive Officer
- Takahiro Suzuki, Ph.D.
- Business
- Research and development of molecular diagnostic technologies and products
- Subsidiary
- Ascella Bio JAPAN, Inc. (Tokyo, Japan)
Ascella Biosystems, Inc. — Headquarters
San Francisco, California
Ascella Bio JAPAN, Inc. — Head office
Minato-ku, Tokyo
Ascella Bio JAPAN, Inc. — Laboratory
Mitsui Link-Lab Kashiwanoha 1, Kashiwa, Chiba
Building the next generation of point-of-care testing, together.
We are seeking development, manufacturing and distribution partners for human IVD and veterinary applications.